Deciphera Pharmaceuticals
ABOUT US
One Mission, Inspired by Patients: Defeat Cancer.
200 Smith Street
Waltham, MA 02451
(781) 209-6400
PRIMARY CONTACTS
Ben Stutzman
Associate Director Market Access
(361) 549-8937
bstutzman@deciphera.com
Nicholas Zeringo
Associate Scientific Director, Medical Affairs
(856) 912-1181
nzeringo@deciphera.com
PRODUCTS OR SERVICES
QINLOCK is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumors (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.